Free tool
Oncology stocks
We cover 80 companies grouped under the Oncology theme. The median market value in the group is $121.50M. Across the group, the median move over the past trading day is 0.00%. 45% of the 71 with a 200-day average trade above it. Price change over the past year runs from −75.2% to +139.7% across the middle 80 percent of the group, with a median of −3.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
80 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% |
| 0J9P.L | Incyte Corporation | $21.10B | Large cap | +53.49% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +50.53% |
| 0M2N.L | Orion Oyj | $11.16B | Large cap | +20.48% |
| 0I3Q.L | Corcept Therapeutics Incorporated | $4.54B | Mid cap | +74.96% |
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | −18.08% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% |
| 0HFQ.L | AnaptysBio, Inc. | $1.20B | Small cap | +187.79% |
| PHIL.MI | Philogen S.p.A. | $1.11B | Small cap | +4.75% |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% |
| 0SZI.L | Corbus Pharmaceuticals Holdings, Inc. | $707.84M | Small cap | +9.60% |
| 0QAV.L | Nanobiotix S.A. | $671.98M | Small cap | +351.98% |
| 0KCS.L | OPKO Health, Inc. | $578.38M | Small cap | +5.64% |
| 0IL8.L | Kyntra Bio, Inc. | $512.46M | Small cap | −28.07% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | $498.50M | Small cap | −90.91% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | $492.64M | Small cap | +1198.08% |
| 0LOV.L | Verastem, Inc. | $470.33M | Small cap | −19.93% |
| AVCT.L | Avacta Group Plc | $440.62M | Small cap | +26.36% |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% |
| 0XOD.L | UroGen Pharma Ltd. | $347.24M | Small cap | +136.88% |
| TNG.PA | Transgene SA | $263.11M | Small cap | −22.50% |
| 0IV3.L | Geron Corporation | $255.34M | Small cap | +7.77% |
| IDD.DE | Innate Pharma S.A. | $243.27M | Small cap | −2.52% |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% |
| BINV.ST | BioInvent International AB (publ) | $162.35M | Small cap | −23.46% |
| 0IMT.L | Photocure ASA | $144.18M | Small cap | −12.66% |
| SCLP.L | Scancell Holdings plc | $136.80M | Small cap | −7.62% |
| HPHA.DE | Heidelberg Pharma AG | $135.27M | Small cap | −31.15% |
| 0RU5.L | Oncoinvent ASA | $128.23M | Small cap | +7339.02% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | $124.97M | Small cap | +80.49% |
| 0RDB.L | Oryzon Genomics S.A. | $121.50M | Small cap | +5.90% |
| RVU.WA | Ryvu Therapeutics S.A. | $115.61M | Small cap | −36.99% |
| FARN.L | Faron Pharmaceuticals Oy | $110.28M | Small cap | −79.24% |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% |
| 0QW5.L | Heidelberg Pharma AG | $84.14M | Micro cap | −33.15% |
| 0J4V.L | Heron Therapeutics, Inc. | $82.85M | Micro cap | −78.12% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| 0QXX.L | Molecular Partners AG | $79.34M | Micro cap | +17.00% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| MAAT.PA | MaaT Pharma SA | $65.60M | Micro cap | −33.91% |
| 0OCQ.L | Transgene SA | $55.45M | Micro cap | −22.31% |
| 0RAD.L | OSE Immunotherapeutics SA | $51.87M | Micro cap | −48.50% |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% |
| COIL.L | Coiled Therapeutics plc | $49.30M | Micro cap | −26.92% |
| SVE.WA | Synthaverse S.A. | $47.18M | Micro cap | −36.25% |
| MOC.WA | Molecure S.A. | $41.03M | Micro cap | −22.39% |
| NNG.WA | NanoGroup S.A. | $28.00M | Micro cap | −17.36% |
| DEX.ST | Dextech Medical AB | $20.09M | Micro cap | +26.38% |
| ALTME.PA | TME Pharma N.V. | $17.97M | Micro cap | +25.97% |
| ABERA.ST | Abera Bioscience AB | $17.69M | Micro cap | +1.61% |
| B8FK.DE | Biofrontera AG | $17.36M | Micro cap | −3.07% |
| ACTI.ST | Active Biotech AB (publ) | $14.50M | Micro cap | −62.00% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| 0NWK.L | Valerio Therapeutics Société anonyme | $10.08M | Micro cap | +1279.03% |
| PUR.WA | MultiQure S.A. | $9.70M | Micro cap | −55.05% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | $7.05M | Micro cap | −19.44% |
| CHOSA.ST | Chosa Oncology AB | $7.01M | Micro cap | −9.00% |
| NFX.L | Nuformix plc | $5.85M | Micro cap | +80.68% |
| 0GP7.L | Medivir AB (publ) | $5.78M | Micro cap | +1.60% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | $3.53M | Micro cap | +11.79% |
| VAL.L | ValiRx plc | $2.78M | Micro cap | −73.04% |
| 0RK9.L | Alligator Bioscience AB (publ) | $2.11M | Micro cap | −99.13% |
| ATORX.ST | Alligator Bioscience AB (publ) | $1.88M | Micro cap | −99.27% |
| PTP.DE | Pentixapharm Holding AG | $1.06M | Micro cap | +5.47% |
| 0GQU.L | Active Biotech AB (publ) | $978.93K | Micro cap | +7801.59% |
| 0A4Y.L | AIM ImmunoTech Inc. | — | — | −89.84% |
| 0GHZ.L | Xspray Pharma AB (publ) | — | — | −74.90% |
| 0HL9.L | Affimed N.V. | — | — | 0.00% |
| 0HS8.L | Lisata Therapeutics, Inc. | — | — | −26.55% |
| 0J7G.L | HUTCHMED (China) Limited | — | — | +9.66% |
| 0K2H.L | Moleculin Biotech, Inc. | — | — | −94.03% |
| 0LC7.L | Syros Pharmaceuticals, Inc. | — | — | −95.00% |
| 0VQ.DE | PureTech Health plc | — | — | +1.50% |
| CURAS.CO | Curasight A/S | — | — | −36.46% |
| MOLN.SW | Molecular Partners AG | — | — | +14.05% |
| T9G.DE | Vidac Pharma Holding Plc | — | — | −38.68% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.